Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Efficacy and Safety of Valemetostat Monotherapy in Patients with Relapsed or Refractory Peripheral T-Cell Lymphomas: Primary Results of the Phase 2 VALENTINE-PTCL01 Study

Blood (2023) 142 (Supplement 1): 302.

https://doi.org/10.1182/blood-2023-179304

Published: 2023

Journal Articles

Spplaash Study: A Randomized Study to Evaluate the Incidence of Postdural Puncture Headache with the Use of Atraumatic Needles in Hematology

Yann Guillermin, Stéphane Morisset, Ugo Thévenet, Emmanuelle Nicolas-Virelizier, Anne-Sophie Michallet, Jerome Cornillon, Manon Sapet, Valentin Daguerre, Emmanuel Beillard, Denis Guyotat, Elisabeth Daguenet, Ludovic Fouillet

Blood (2023) 142 (Supplement 1): 129.

https://doi.org/10.1182/blood-2023-180601

Published: 2023

Journal Articles

Long-Term Outcome of Multiple Myeloma Patients Receiving Autologous Stem Cell Transplantation (ASCT) - Impact of Therapeutic Strategy Following ASCT

Emilie Martin, Stéphane Morisset, Mohamad Sobh, Alfred Quillon, Hélène Boyer, Philippe Rey, Emmanuelle Nicolas-Virelizier, Amine Belhabri, Yann Guillermin, Laure Lebras, Valérie Mialou, Jean Paul Bourgeot, Melinda Teyssier, Anne-Sophie Michallet, Mauricette Michallet

Blood (2023) 142 (Supplement 1): 6682.

https://doi.org/10.1182/blood-2023-182700

Published: 2023

Journal Articles

A Genomic Approach for High-Grade B Cell Lymphoma with MYC and BCL2 and / or BCL6 Rearrangements: Two Clusters Stood out on Next Generation Sequencing Results

Yann Guillermin, Pierre Sesques, Claire Mauduit, Arsène Vacherot, Marie-Charlotte Laude, Anne-Sophie Michallet, Catherine Chassagne, Alexandra Traverse-Glehen, Emmanuel Beillard

Blood (2023) 142 (Supplement 1): 6097.

https://doi.org/10.1182/blood-2023-182979

Published: 2023

Journal Articles

The ALK-OBS Trial: Results of a Multicenter Prospective Study Assessing the Prognostic Value of New Markers in Adults with ALK-Positive ALCL Treated By CHOEP: A Lysa Study

Blood (2022) 140 (Supplement 1): 3680–3682.

https://doi.org/10.1182/blood-2022-170841

Published: 2022

Journal Articles

Characteristics and Outcomes of Adult Patients with T Prolymphocytic Leukemia: A Real World Study of the French Innovative Leukemia Group (FILO)

Blood (2022) 140 (Supplement 1): 1485–1487.

https://doi.org/10.1182/blood-2022-157399

Published: 2022

Journal Articles

A Genomic Approach in High-Grade B Cell Lymphoma with MYC and BCL2 and / or BCL6 Rearrangements: Two Clusters Stood out on Next Generation Sequencing Results

Arsène Vacherot, Emmanuel Beillard, Catherine Chassagne-Clément, Marie-Charlotte Laude, Pierre Sesques, Laure Lebras, Alexandra Traverse-Glehen, Claire Mauduit, Mauricette Michallet, Stéphane Morisset, Anne-Sophie Michallet, Yann Guillermin

Blood (2022) 140 (Supplement 1): 11878–11879.

https://doi.org/10.1182/blood-2022-169510

Published: 2022

Journal Articles

Venetoclax Pharmacokinetics in Real World AML Patients: A Real Candidate for Therapeutic Drug Monitoring

Michael Philippe, Jerome Guitton, Bertrand Favier, Clemence Santana, Emmanuelle Nicolas-Virelizier, Yann Guillermin, Anne-Sophie Michallet, Mauricette Michallet, Amine Belhabri

Blood (2022) 140 (Supplement 1): 6179–6180.

https://doi.org/10.1182/blood-2022-168327

Published: 2022

Journal Articles

Preliminary Study of Ruxolitinib and Venetoclax for Treatment of Patients with T-Cell Prolymphocytic Leukemia Refractory to, or Ineligible for Alemtuzumab

Charles Herbaux, Stéphanie Poulain, Damien Roos-Weil, Jacques-Olivier Bay, Yann Guillermin, Francois Lemonnier, Kamel Laribi, Sorin Visanica, Jerome Moreaux, Hugo Gonzalez, Maxime Jullien, Abderrazak El Yamani, Houria Debarri, Sophie Godet, Franck Morschhauser, Olivier Tournilhac, Matthew S. Davids, Loic Ysebaert

Blood (2021) 138 (Supplement 1): 1201.

https://doi.org/10.1182/blood-2021-149228

Published: 2021

Journal Articles

Study of Treatment Complications in Oncology / Hematology Patients: Protocol for a Prospective and Interventional Cohort Study from the Pasca Program

Mauricette Michallet, MD PhD, Romain Buono, PharmD, Mohamad Sobh, PharmD, Solene Poirey, Emmanuelle Nicolas-Virelizier, MD, Souad Assaad, MD, Amine Belhabri, MD, Laure Lebras, MD, Yann Guillermin, MD, Philippe Rey, MD, Aude Flechon, MD PhD, Helen Boyle, MD, Franck E Nicolini, MDPhD, Audrey Couillet, Gisele Chvetzoff, Jean-Yves Blay, MD PhD, Beatrice Fervers, Anne-Sophie Michallet, MD PhD

Blood (2020) 136 (Supplement 1): 10–11.

https://doi.org/10.1182/blood-2020-142355

Published: 2020

Journal Articles

Characteristics and Outcomes of Therapy-Related Acute Myeloid Leukemia: Results of Retrospective Analysis of 116 Adult Patients

Amine Belhabri, MD, Liliana Vila, MD, Mael Heiblig, Stephane Morisset, BioStat, Emmanuelle Nicolas-Virelizier, MD, Clémence Santana, MD, Isabelle Tigaud, MD, Sandrine Hayette, PhD, Anne-Sophie Michallet, MD PhD, Philippe Rey, MD, Yann Guillermin, MD, Souad Assad, MD, Laure Lebras, MD, Mauricette Michallet, MD PhD

Blood (2020) 136 (Supplement 1): 27–28.

https://doi.org/10.1182/blood-2020-142956

Published: 2020

Journal Articles

Personalised Follow-up Program after Acute Phase of Treatment in Oncology/Hematology Patients Towards Early Intervention, Better Care and Quality of Life Improvement: Results from Pasca Pilot Study

Mauricette Michallet, MD PhD, Mohamad Sobh, PharmD, Romain Buono, Solene Poirey, Isabela Pascu, Emmanuelle Nicolas-Virelizier, MD, Souad Assaad, MD, Amine Belhabri, Laure Lebras, MD, Yann Guillermin, MD, Philippe Rey, MD, Lila Gilis, MD, Franck E Nicolini, MD PhD, Stephane Morisset, BioStat, Audrey Couillet, Gisele Chvetzoff, Jean-Yves Blay, MD PhD, Beatrice Fervers, Anne-Sophie Michallet, MD PhD

Blood (2019) 134 (Supplement_1): 5817.

https://doi.org/10.1182/blood-2019-130597

Published: 2019

Journal Articles

Comparison Of BCR-ABL1/ABL1 and BCR-ABL1/GUS Ratios At Different Clinical Decision Cut-Offs In Chronic Phase Chronic Myelogenous Leukemia Patients On Imatinib

Sarah Huet, Denis Souche, Jean-Pierre Magaud, Pascale Cony-Makhoul, MD, Yann Guillermin, MD, Mael Heiblig, MD, Mauricette Michallet, MD, PhD, Franck E. Nicolini, MD, PhD, Sandrine Hayette, PhD

Blood (2013) 122 (21): 2713.

https://doi.org/10.1182/blood.V122.21.2713.2713

Published: 2013

Journal Articles

Cardio-Vascular Events Occurring On Ponatinib In Chronic Phase Chronic Myeloid Leukemia Patients, Preliminary Analysis Of a Multicenter Cohort

Franck E. Nicolini, MD, PhD, Marie-Claude Gagnieu, PharmD, PhD, Mael Heiblig, MD, Emilie Blond, Pharm.D, Laurence Legros, MD, PhD, Yann Guillermin, MD, Stephane Morisset, Stat., Fiorenza Barraco, MD, Madeleine Etienne, CRA, Oriane Le Borgne, CRA, Jeremy Ruby, CRA student, Mohamad Sobh, Pharm.M., Gaelle Richard-Colmant, MD, Celine Fettig, Tech., Mauricette Michallet, MD, PhD, Delphine Rea, MD, PhD

Blood (2013) 122 (21): 4020.

https://doi.org/10.1182/blood.V122.21.4020.4020

Published: 2013

Journal Articles

Prediction Of Second Generation Tyrosine Kinase Inhibitors Response After Imatinib Failure: The Value Of The Hammersmith Prediction Score

Franck E. Nicolini, MD, PhD, Philippe Rousselot, MD, PhD, Stephane Giraudier, MD, PhD, Gabriel Etienne, MD, PHD, Hyacinthe Johnson-Ansah, MD, Lydia Roy, MD, Pascale Cony-Makhoul, MD, Yann Guillermin, MD, Mohamad Sobh, Pharm.M., Pierre Marie, CRA, Driss Kamar, Biostat, Hesham Mohamed, MD, Denis Caillot, MD, Delphine Rea, MD, PhD

Blood (2013) 122 (21): 383.

https://doi.org/10.1182/blood.V122.21.383.383

Published: 2013

Journal Articles

CML Patients Show Sperm Alterations At Diagnosis That Are Not Improved On Tyrosine Kinase Inhibitor Treatment

Franck E. Nicolini, MD, PhD, Françoise Huguet, Hélène Labussière-Wallet, MD, Yann Guillermin, MD, Madeleine Etienne, CRA, Marie-Pierre Fort, CRA, Isabelle Tigaud, MD, Sandrine Hayette, Stephane Morisset, Stat., Mohamad Sobh, Pharm.M., Fiorenza Barraco, MD, Mauricette Michallet, MD, PhD, Myriam Daudin, MD, Volcy Soula, MD, Sandrine Giscard d'Estaing, MD, Gabriel Etienne, MD, PhD

Blood (2012) 120 (21): 1669.

https://doi.org/10.1182/blood.V120.21.1669.1669

Published: 2012

Journal Articles

Lymphoma Occurring Over the Age of 90: Clinical Presentation and Outcome

Adrien Trebouet, Tony Marchand, Richard Lemal, Emmanuel Gyan, MD, PhD, Florence Broussais, MD, Yann Guillermin, MD, Hélène Monjanel, Gilles Salles, MD, Steven Le Gouill, Stephanie Boulanger, Sandra Leguyader, Albert Collignon, Delphine Rossille, PhD, Catherine Thieblemont, MD, PhD, Thierry Lamy, MD, PhD, Roch Houot, MD, PhD

Blood (2012) 120 (21): 1582.

https://doi.org/10.1182/blood.V120.21.1582.1582

Published: 2012

Journal Articles

Analysis of Clinical Arterial and Metabolic Parameters in Chronic Phase CML Patients On Nilotinib in a Single Center Cohort

Hélène Labussière-Wallet, MD, Yann Guillermin, MD, Madeleine Etienne, CRA, Anne-Claire Barale, Caroline Serrier, MD, Isabelle Tigaud, MD, Sandrine Hayette, Oriane Le Borgne, CRA, Mohamad Sobh, Pharm.M., Stephane Morisset, Stat., Fiorenza Barraco, MD, Mauricette Michallet, MD, PhD, Franck E. Nicolini, MD, PhD

Blood (2012) 120 (21): 3756.

https://doi.org/10.1182/blood.V120.21.3756.3756

Published: 2012

NARROW

Efficacy and Safety of Valemetostat Monotherapy in Patients with Relapsed or Refractory Peripheral T-Cell Lymphomas: Primary Results of the Phase 2 VALENTINE-PTCL01 Study

Spplaash Study: A Randomized Study to Evaluate the Incidence of Postdural Puncture Headache with the Use of Atraumatic Needles in Hematology

Long-Term Outcome of Multiple Myeloma Patients Receiving Autologous Stem Cell Transplantation (ASCT) - Impact of Therapeutic Strategy Following ASCT

A Genomic Approach for High-Grade B Cell Lymphoma with MYC and BCL2 and / or BCL6 Rearrangements: Two Clusters Stood out on Next Generation Sequencing Results

The ALK-OBS Trial: Results of a Multicenter Prospective Study Assessing the Prognostic Value of New Markers in Adults with ALK-Positive ALCL Treated By CHOEP: A Lysa Study

Characteristics and Outcomes of Adult Patients with T Prolymphocytic Leukemia: A Real World Study of the French Innovative Leukemia Group (FILO)

A Genomic Approach in High-Grade B Cell Lymphoma with MYC and BCL2 and / or BCL6 Rearrangements: Two Clusters Stood out on Next Generation Sequencing Results

Venetoclax Pharmacokinetics in Real World AML Patients: A Real Candidate for Therapeutic Drug Monitoring

Preliminary Study of Ruxolitinib and Venetoclax for Treatment of Patients with T-Cell Prolymphocytic Leukemia Refractory to, or Ineligible for Alemtuzumab

Study of Treatment Complications in Oncology / Hematology Patients: Protocol for a Prospective and Interventional Cohort Study from the Pasca Program

Characteristics and Outcomes of Therapy-Related Acute Myeloid Leukemia: Results of Retrospective Analysis of 116 Adult Patients

Personalised Follow-up Program after Acute Phase of Treatment in Oncology/Hematology Patients Towards Early Intervention, Better Care and Quality of Life Improvement: Results from Pasca Pilot Study

Comparison Of BCR-ABL1/ABL1 and BCR-ABL1/GUS Ratios At Different Clinical Decision Cut-Offs In Chronic Phase Chronic Myelogenous Leukemia Patients On Imatinib

Cardio-Vascular Events Occurring On Ponatinib In Chronic Phase Chronic Myeloid Leukemia Patients, Preliminary Analysis Of a Multicenter Cohort

Prediction Of Second Generation Tyrosine Kinase Inhibitors Response After Imatinib Failure: The Value Of The Hammersmith Prediction Score

CML Patients Show Sperm Alterations At Diagnosis That Are Not Improved On Tyrosine Kinase Inhibitor Treatment

Lymphoma Occurring Over the Age of 90: Clinical Presentation and Outcome

Analysis of Clinical Arterial and Metabolic Parameters in Chronic Phase CML Patients On Nilotinib in a Single Center Cohort

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only